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ABSTRACT
Objectives: To evaluate a multidisciplinary team
(MDT) case management intervention, at the individual
(direct effects of intervention) and practice levels
(potential spillover effects).
Design: Difference-in-differences design with multiple
intervention start dates, analysing hospital admissions
data. In secondary analyses, we stratified individual-
level results by risk score.
Setting: Single clinical commissioning group (CCG) in
the UK’s National Health Service (NHS).
Participants: At the individual level, we matched
2049 intervention patients using propensity scoring
one-to-one with control patients. At the practice level,
30 practices were compared using a natural experiment
through staged implementation.
Intervention: Practice Integrated Care Teams (PICTs),
using MDT case management of high-risk patients
together with a summary record of care versus usual
care.
Direct and indirect outcome measures: Primary
measures of intervention effects were accident and
emergency (A&E) visits; inpatient non-elective stays,
30-day re-admissions; inpatient elective stays;
outpatient visits; and admissions for ambulatory care
sensitive conditions. Secondary measures included
inpatient length of stay; total cost of secondary care
services; and patient satisfaction (at the practice level
only).
Results: At the individual level, we found slight,
clinically trivial increases in inpatient non-elective
admissions (+0.01 admissions per patient per month;
95% CI 0.00 to 0.01. Effect size (ES): 0.02) and
30-day re-admissions (+0.00; 0.00 to 0.01. ES: 0.03).
We found no indication that highest risk patients
benefitted more from the intervention. At the practice
level, we found a small decrease in inpatient non-
elective admissions (−0.63 admissions per 1000
patients per month; −1.17 to −0.09. ES: −0.24).
However, this result did not withstand a robustness
check; the estimate may have absorbed some
differences in underlying practice trends.
Conclusions: The intervention does not meet its
primary aim, and the clinical significance and cost-
effectiveness of these small practice-level effects is
debatable. There is an ongoing need to develop
effective ways to reduce unnecessary attendances in
secondary care for the high-risk population.
INTRODUCTION
An ageing population with increasing
number of long-term conditions (LTCs) and
complex multimorbidity1 2 has caused policy-
makers to rethink delivery of care.3
There is increasing focus on the beneﬁts of
‘integrated care’, to enable a more efﬁcient
and effective response to LTCs.3 4 There is no
consensus deﬁnition of what constitutes ‘inte-
grated care’,5 and the concept describes many
different changes to the health system that
can occur at multiple levels.6 7 8 Practical
implementation examples of integrated care
include pooling of funds, joint commission-
ing, colocation of services, shared clinical
records, and at the interface of the health
system with the patient (ie, service delivery
level) multidisciplinary team (MDT) working
and case management.7 8
In the UK’s National Health Service
(NHS), a common model of integrated care
is the use of ‘multi-disciplinary team (MDT)
case management of high-risk patients’.9 10
Strengths and limitations of this study
▪ This study addresses a number of shortcomings
found in related literature from a recent system-
atic review.
▪ The difference-in-differences methods can
provide a rigorous assessment under certain
conditions while evaluating an intervention in a
real-world setting.
▪ Results are analysed and presented at two levels
to show direct effects of the intervention, as well
as wider spillover effects of integrated care.
▪ At the practice level, there may be some selec-
tion bias due to voluntary recruitment, although
we predict this to be minimal based on our
robustness checks.
▪ At the individual level, results may be prone to
some bias in favour of control participants due
to the ongoing recruitment strategy versus a
single time point propensity matching. Again, we
predict this to be minimal, as participants and
controls were well matched at the first start date.
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We undertook a systematic review of this model of
integrated care and found few effects across a number
of relevant outcomes, barring a small effect on patient
satisfaction, and short-term changes in self-reported
health status.6
We also identiﬁed gaps in the current literature. In
the review, 78% of included studies were randomised
controlled trials (RCTs).6 We suggested a complemen-
tary role for rigorous quasi-experiments in routine set-
tings to better balance internal and external validity.11 12
The majority of studies also measured only direct
(individual-level) effects. MDT case management used
to manage a subset of patients could lead to broader
changes, such as better ‘professional integration’
through team working.13 14 These broader changes
could lead to effects on the wider patient population,
beyond those patients speciﬁcally managed by the MDT
(what we call ‘spillover effects’).
Our contribution to the evidence base for MDT case
management thus involved an evaluation of a local inte-
grated care intervention using a robust quasi-experimental
study design. We model effects using two distinct analyses:
(1) individual-level analysis (to capture direct effects of the
intervention) and (2) practice-level analysis (to capture
any potential spillover effects).
The intervention
In Central Manchester, the MDT case management is
achieved through Practice Integrated Care Teams
(PICTs) introduced by the clinical commissioning group
(CCG). PICTs conduct case ﬁnding, assess the needs of
the individual identiﬁed, prepare individualised care
plans, co-ordinate care and conduct regular review, mon-
itoring and adaptation of the care plan.15 The aim of
the intervention was to reduce unnecessary attendances
in secondary care for the high-risk population.16
Table 1 gives an overview of the key aspects of the inter-
vention. Compared with our previous systematic review of
similar interventions, it is fairly common, where we iden-
tiﬁed the majority (58%) employing MDT case manage-
ment (as opposed to a single case manager), and a
predictive risk model as the primary method of identify-
ing suitable patients.6 Less commonly, this intervention
took place in a system ranked as delivering ‘high’ strength
of primary care (ie, strength of primary healthcare orien-
tation of the health system as classiﬁed by Starﬁeld and
Shi17—the majority in the review came from a ‘low’-
strength system, eg, USA: 64%). Additionally, the PICT
intervention included involvement of a social worker
(33% of studies involved a social worker in our previous
review), providing further potential for ‘horizontal inte-
gration’ (ie, integration between separate organisations
at the same level of the health system).3
METHODS
Our study used a quasi-experimental pre–post design
with a suitable control group to examine any change in
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outcomes induced by a policy change intervention—an
adapted version of difference-in-differences (DD)
analysis.18
We prepared and analysed data at two distinct levels,
each described separately below. Owing to a data govern-
ance issue at the CCG, intervention patients could not
be identiﬁed at the individual level until nearly all prac-
tices implemented the intervention (patients were not
consented prior to this date, so those joining before
could not be included in the analysis—they were also
excluded from our control group, so no contamination
occurred). Figure 1 summarises the period of analysis
for the individual and practice levels, showing the ana-
lysis and ‘pretrend’ period (ie, period prior to any prac-
tice/individual joining the intervention group) for each.
With the PICT intervention having no single start
date, we adapted our analysis to allow for this staged
introduction (using a time ﬁxed effect instead of the
usual binary post dummy—see equations in practice
level and individual level sections in the online
supplementary material appendices).18 19 The main dif-
ference from the standard DD approach is that the inter-
vention and control groups are not static over time,
allowing intervention patients/practices to join gradually
over the monthly panel datasets, and comparing appro-
priately at each time point. This method has been used
previously in the literature,19 20 and we have adapted it
to suit data at both of our levels of analyses (explained
below, and in more detail in the online supplementary
material appendices).
We analysed anonymised data held by the CCG, from
the ‘admitted patient care commissioning dataset’,
submitted by all providers in England via the Secondary
Uses Service (SUS). The dataset included all patient
contacts with secondary care services, demographic data,
as well as costs calculated through the national payment
by results (PbR, together with local prices for local provi-
ders where applicable). For the analysis of pseudony-
mised/anonymised data, no formal ethics process was
deemed necessary. The CCG had themselves previously
consented the intervention individuals for use of their
data for evaluation purposes. For patient satisfaction at
the practice level, we used data from the GP Patient
Survey (GPPS—see online supplementary material
appendices).
Data preparation and analysis
All data preparation and analysis was carried out using
STATA (V.13) (StataCorp. Stata Statistical Software: Release
13. College Station, TX: StataCorp LP., 2013). The DD
analysis estimate is unbiased only under the key assump-
tion that the average difference between intervention
and control units’ trends would be the same in the
absence of ‘treatment’ (ie, the PICT intervention).18
This ‘parallel trends’ assumption is key to DD analysis
and was tested graphically and statistically for each
outcome assessed, at each analysis level (see online
supplementary material appendices for graphs).
We analysed data distinctly at two levels:
1. Individual level: primary analysis
At the individual level, to obtain parallel pretrends, it
was necessary to propensity match intervention patients
to controls from within the same CCG (we matched on
the characteristics for which the patients were recruited
Figure 1 Timeline of analyses
highlighting key dates of practices
and individual patients included in
analysis joining the intervention.
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in practice to maximise comparability—see online
supplementary material appendices for details). We then
analysed 2049 intervention patients versus 2049 matched
controls using the best-ﬁtting count model for each
outcome.21 Outcome measures were summed to a count
per patient per month over the period September 2010–
March 2015 inclusive, to allow a 3-year pretrend period.
In all models, we adjusted for relevant individual cov-
ariates from the directed acyclic graph (DAG—see
online supplementary material appendices),22 as well as
practice ﬁxed effects (to control for any effects caused
by characteristics of a speciﬁc practice rather than the
intervention itself).23 We cluster our SEs by practice to
deal with concerns of serial correlation.24 We took the
average partial effect of results (for β2—see online
supplementary material appendices for equation) and
report these below (ie, the covariates adjusted absolute
change in counts per patient per month). We addition-
ally report the effect size (ES; standardised mean differ-
ence) as a measure of practical signiﬁcance of each
result.25 We adopted Cohen’s rule of thumb for inter-
preting ESs, that is, 0.2 indicates a small effect, 0.5 a
medium and 0.8 a large effect.26
Stratification by risk score
Patients were recruited to the intervention via risk tool
score and clinical judgement. To test whether the
highest risk patients (according to risk tool score) bene-
ﬁtted more from the PICT intervention than those with
lower calculated risks also treated, we generated a ‘high-
risk’ dummy. We reran the individual-level analysis with
a difference-in-difference-in-differences (DDD) analysis,
using an additional interaction term to determine sub-
group effects (see online supplementary material appen-
dices for equation).
2. Practice level: secondary analysis of spillover effects
At the practice level, practices gradually took up the
intervention over a period of 18 months. At each time
point (updating monthly in our dataset), the time ﬁxed
effects compare all intervention practices with all ‘con-
trols’ (ie, all those practices that have not yet adopted
the intervention, even though they will later adopt the
intervention).19 20 Outcomes were summed to a count
per 1000 patients per month for each of the practices
and analysed over the period September 2010–March
2015 inclusive, to overlap with the individual-level
analysis.
We used a linear regression model, adjusting for ﬁxed
effects for each practice and time period (monthly—see
online supplementary material appendices for equa-
tion). We cluster our SEs by practice to deal with con-
cerns of serial correlation.24
Outcome measures
Primary outcome measures for both analyses included:
▸ Inpatient non-elective admissions
▸ Re-admissions (30 days)
▸ Inpatient elective admissions
▸ Accident and emergency (A&E) visits
▸ Outpatient visits
▸ Admissions for ambulatory care sensitive conditions
(ACSCs, which we used as a measure of patient safety
in a health system with universal health coverage—
see online supplementary material appendices for
details)
Secondary outcome measures included:
▸ Total cost of secondary care services (£)
▸ Length of stay (inpatient)
▸ Patient satisfaction (practice level only: measured
through the GPPS—see online supplementary
material appendices)
– General satisfaction
– LTC-speciﬁc satisfaction
Robustness check
At both levels of analysis, we additionally added a robust-
ness check including a practice-speciﬁc time trend. This
allows intervention and control practices to follow differ-
ent trends and can help reveal any indication of the
observed effect having absorbed any differences in
underlying practice time trends.18
At the practice level only, due to the voluntary roll-out
of the intervention, we attempted to assess the effects of
selection bias using a logistic regression model (includ-
ing % males; % over 65; practice list size; number of
general practitioners (GPs) per thousand patients; total
Index of Multiple Deprivation (IMD) score 2010; and
total % Quality and Outcomes Framework (QOF)
achievement score).27 We additionally reran the practice-
level analysis excluding those practices recruited to the
intervention in wave 1, assuming these to be the prac-
tices at most risk of selection bias if it did indeed
occur.19
RESULTS
Individual-level analysis
Sample characteristics
A total of 2049 intervention patients were propensity
score matched to non-intervention patients from the
same CCG. As expected, the differences were small
between matched patient baseline characteristics (see
table 2).
Table 3 shows the crude absolute differences in mean
outcome measures (PICT patients vs matched controls).
As for the DD results in the section below, a negative
estimate indicates a relative decrease in admissions for
PICT patients compared with controls (ie, a negative
intervention effect favours the intervention).
DD parallel pretrends
We identiﬁed evidence of a signiﬁcant difference
between pretrends for outpatient visits at the individual
level. This variable was potentially biased towards a
result favouring the PICT intervention over controls.
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However, we found no statistically signiﬁcant result
favouring either group. All other variables satisﬁed the
parallel trends assumption, with no indication of bias.
DD results
Table 4 shows the DD analysis results at the individual
level. After adjustment for age, cumulative multimorbid-
ity, IMD domains (excluding health) and practice and
time ﬁxed effects, we found a slight increase in inpatient
non-elective admissions (0.0053 per patient per month;
95% CI 0.0004 to 0.0102) and 30-day inpatient
readmissions (0.0041; 0.0018 to 0.0064). The ESs (0.02
and 0.03) were small.26
Robustness check
All of the estimates withstood the addition of a practice-
speciﬁc time trend.
Stratification by risk score
We observed no relationship between risk score and
time of recruitment into the intervention. Observing the
plots of risk score versus total postintervention
Table 2 Individual baseline characteristics (before and after matching)
Before matching After matching
Mean (unless otherwise indicated) PICT (SD) Controls (SD) SMD PICT (SD) Controls (SD) SMD
N 2049 93 532 2049 2049
Male (%) 44.3 47.4 44.3 44.1
Age 67.2 (17.8) 35.3 (22.2) −1.44 67.2 (17.8) 65.8 (18.7) −0.07
IMD 2010 40.2 (14.8) 40.6 (16.0) 0.03 40.2 (14.8) 40.2 (15.8) 0.00
MM count baseline 2.7 (2.1) 0.7 (1.2) −1.63 2.7 (2.1) 2.4 (2.2) −0.12
Previous inpatient admissions 1.3 (2.1) 0.3 (1.1) −0.88 1.3 (2.1) 1.2 (2.2) −0.05
Previous outpatient visits 7.0 (9.6) 1.9 (4.3) −1.14 7.0 (9.6) 7.2 (9.8) 0.02
Previous A&E visits 1.4 (2.4) 0.5 (1.2) −0.73 1.4 (2.4) 1.4 (2.5) 0.00
Previous admissions calculated for period 31 August 2012–1 September 2013 (12 months prior to the first intervention patient start date).
A&E, accident and emergency; IMD, Index of Multiple Deprivation; PICT, Practice Integrated Care Team; SMD, standardised mean difference.
Table 3 Average absolute outcomes per patient per month by PICT, preintervention/postintervention
Outcome
Mean (per
patient per month)
Difference
Unadjusted intervention effect
(difference per patient per month)Pre Post
Primary outcomes
Inpatient non-electives
Controls 0.0362 0.0422 0.006
PICT 0.0550 0.0704 0.0154 0.0094
Inpatient electives
Controls 0.0365 0.0369 0.0004
PICT 0.0438 0.0451 0.0013 0.0009
Outpatient admissions
Controls 0.5019 0.5611 0.0592
PICT 0.5701 0.7188 0.1487 0.0895
A&E visits
Controls 0.0808 0.0805 −0.0003
PICT 0.1061 0.1217 0.0156 0.0159
ACSCs
Controls 0.0059 0.0078 0.0019
PICT 0.0093 0.0124 0.0031 0.0012
Re-admissions (30 days)
Controls 0.0069 0.0082 0.0013
PICT 0.0115 0.0191 0.0076 0.0063
Secondary outcomes
Total cost of secondary care services (£)
Controls 168.8746 195.1289 26.2543
PICT 215.0091 276.9591 61.9500 35.6957
Length of stay (days)
Controls 0.3943 0.4888 0.0945
PICT 0.5624 0.7903 0.2279 0.1334
A&E, accident and emergency; ACSCs, ambulatory care sensitive conditions; PICT, Practice Integrated Care Team.
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admissions, however, we see that there does appear to be
a relationship between a higher risk score and increased
non-elective admissions, A&E visits, total cost of second-
ary care services, admissions for ACSCs, inpatient length
of stay and inpatient 30-day readmissions (see online
supplementary material appendices). This implies that
the risk score is a good predictor of these future admis-
sion types, as expected.
Results of the DDD analysis, however, indicate that
those patients with a higher risk score did not beneﬁt
more from the intervention, and instead showed statistic-
ally signiﬁcant increased inpatient non-elective admis-
sions (0.0208 per patient per month; 95% CI 0.0083 to
0.0333. ES: 0.09), A&E visits (0.0363; 0.0128 to 0.0598.
ES: 0.09) and inpatient length of stay (0.3071; 0.0592 to
0.5549. ES: 0.06—see online supplementary material
appendices for full list of DDD estimates) compared
with others. Again, the ESs indicate these increases were
slight.
Practice-level analysis
Sample characteristics
Table 5 shows the practice characteristics of the interven-
tion and control practices included in the analysis
(comparing the practices which joined the intervention
in wave 1 with those that joined the intervention at a
later date). On average, the practices are very similar,
with wave 1 practices with a slightly higher proportion of
older patients, and a slightly more even male/female
split.
Table 6 shows the crude absolute differences in mean
outcome measures (per 1000 patients per month)
observed between the wave 1 PICT practices and those
practices joining at a later date (shown as ‘controls’ for
illustration purposes), preintervention and postinterven-
tion. As for the DD results in the section below, a nega-
tive estimate indicates a relative decrease in admissions
for PICT practices compared with controls. For satisfac-
tion outcomes, a positive estimate indicates increased
satisfaction for the intervention practices compared to
usual care.
DD parallel pretrends
We identiﬁed no signiﬁcant differences between pre-
trends for any outcome at the practice level. These data
satisfy the parallel trends assumption, with no indication
of bias.
Table 4 Individual-level adjusted model results
Outcome
Adjusted* intervention effect (95% CI)
(difference per patient per month)
Effect size†Count (NBREG) model
Primary outcomes
Inpatient non-electives 0.0053 (0.0004 to 0.0102)‡ 0.02
Inpatient electives −0.0011 (−0.0092 to 0.0070) −0.00
Outpatient visits 0.0399 (−0.0068 to 0.0866) 0.03
A&E visits 0.0103 (−0.0001 to 0.0207) 0.03
ACSCs 0.0001 (−0.0017 to 0.0020) 0.00
Re-admissions (30 days) 0.0041 (0.0018 to 0.0064)‡ 0.03
Secondary outcomes
Total cost of secondary care services (£)§ 8.1687 (−16.0021 to 32.3396) 0.01
Length of stay (days) 0.0528 (−0.1094 to 0.2151) 0.01
N=224 898 observations; 4098 individuals (period September 2010–March 2015).
bold: withstands practice×time robustness check.
*Adjusted for age, cumulative multimorbidity, IMD domains (excluding health), and practice and time fixed effects. Marginal effects on
PICT×Post reported.
†Standardised mean difference.
‡Significant at p<0.05.
§Zero-inflated negative binomial model based on admission events. A&E, accident and emergency; ACSCs, ambulatory care sensitive
conditions; IMD, Index of Multiple Deprivation; NBREG, negative binomial regression.
Table 5 Practice characteristics (wave 1 compared to later joining practices)
Mean (unless otherwise indicated) PICT—wave 1 (SD) Controls—later joining (SD) SMD
N 12 18
Male (proportion of practice) 0.52 (0.04) 0.54 (0.05) 0.04
Over 65 years (proportion of practice) 0.09 (0.03) 0.07 (0.04) −0.15
IMD 2010 38.5 (10.7) 37.4 (7.7) −0.12
Practice list size 6022.9 (2656.2) 6879.1 (3503.9) 0.27
GPs per thousand 0.6 (0.1) 0.8 (0.5) 0.29
GPs, general practitioners; IMD, Index of Multiple Deprivation; PICT, Practice Integrated Care Team; SMD, standardised mean difference.
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DD results
Table 7 shows the DD analysis results at the practice
level. After adjustment for practice and time ﬁxed
effects, the difference for inpatient non-elective admis-
sions was signiﬁcant, with an estimated −0.63 admissions
per 1000 patients per month (95% CI −1.17 to −0.09)
for PICT practices compared with control practices.
The practical signiﬁcance, as evidenced by the ES of
−0.24, suggests a small effect of PICT on inpatient
non-elective admissions at the practice level.
Robustness check
Following our robustness check, including a practice-
speciﬁc time trend, the estimate for inpatient
non-electives was no longer signiﬁcant: −0.52 (−1.05 to
0.01. ES: −0.20). This may suggest that the intervention
effect has absorbed some differences between treated
practices due to an underlying practice-speciﬁc time
trend (which can happen when policies are implemen-
ted at different points in time in different units, ie, the
practice time trend which was occurring already can
drive the results, so once we control for this, the esti-
mated effect is driven towards zero).18 The ES, however,
remained similar to the result reported above.
We were unable to predict wave 1 entry from the
characteristics we included in our logistic regression
model. Thus, we conclude that selection bias into early
adoption, based on these characteristics at least, was
minimal. However, this does not preclude the presence
of selection bias based on unmeasured characteristics.
When we removed wave 1 practices (assuming these to
be at most risk of selection bias, if it did indeed occur),
statistical power was reduced (as expected), and the SEs
of our estimates were inﬂated. Subsequently, we found
no signiﬁcant results following this robustness check.
The estimate for inpatient non-elective admissions never-
theless remained negative (ie, in favour of the interven-
tion—see online supplementary material appendices for
full list of estimates following this robustness check).
DISCUSSION
For direct effects of the intervention, this study ﬁnds
some statistically signiﬁcant differences between groups,
although effects are very small. The results of our DDD
analysis show that even the highest risk patients (as
deﬁned by the risk prediction tool) treated did not
beneﬁt from the intervention, and in fact admissions for
a number of outcomes (inpatient non-electives, A&E
visits and inpatient length of stay) increased slightly for
these patients.
Additional analysis at the practice level ﬁnds indica-
tions of potentially small positive spillover effects of inte-
grated working at a higher system level. In particular, we
identiﬁed a possible reduction in inpatient non-elective
admissions (which, however, did not hold up to our
robustness check). However, even if these effects are
caused by the intervention, which this study cannot
prove beyond doubt, the absolute difference observed in
the analysis is small.26 For an average practice of
approximately 6000 patients, this would equate to an
estimated difference (not an absolute reduction) of
−45.6 (95% CI −84.0 to −6.6) inpatient non-elective
admissions in a year compared to usual care. If we esti-
mate the average cost of an inpatient non-elective admis-
sion to be £1489,28 this would potentially translate to a
£67 898 (95% CI £125 076 to £9827) difference com-
pared to usual care, before accounting for intervention
costs. While we did not have data on the precise inter-
vention costs of PICT, the national Directed Enhanced
Service (DES), which incentivises similar case manage-
ment interventions, paid an average-sized practice £5175
for implementing the intervention in 2013/2014.29 This
extra incentive cost of course does not account for
actual additional costs of running the intervention, for
example, physician time, overheads and opportunity cost
of a fairly time-intensive intervention, which would also
need to be considered. Additionally, our analysis found
no signiﬁcant effect on total secondary care costs rea-
lised during the study period, with a presumable
increase in primary care costs to run the intervention
(although we did not have data available on primary
care costs, so cannot say for certain). Therefore, beyond
the cautions we have identiﬁed for this potential spill-
over beneﬁt (ie, absence of a primary effect, and not
holding up to robustness checks), cost-effectiveness of
the intervention remains questionable.
Comparison of direct and spillover effects
The apparently contradictory ﬁndings at the two levels
analysed merit speciﬁc discussion. First, it is worth high-
lighting the small proportion of patients managed by
the PICT teams directly (a stipulated 2% of each prac-
tice’s highest risk adult patients). The ﬁnal pool of inter-
vention patients we analysed (n=2049), therefore, only
constitutes 1.04% of the patient population in the 30
practices. The likelihood of the direct effects of the
intervention being a driver for practice-level results in
terms of numbers treated is therefore negligible.
Second, the patients that were targeted directly by the
intervention are by deﬁnition the highest risk, and
potentially beyond the means of a medical intervention
causing signiﬁcant impact at all. This may be particularly
true in the short term, for exacerbation of what are (fre-
quently many) LTCs.30 Our DDD analysis adds evidence
to this effect. Perhaps then, the lower risk patients in the
practice would be more likely to beneﬁt from multidis-
ciplinary working.
Additionally, some qualitative work commissioned by
the CCG separately reveals that some features of the
intervention at the patient level did not occur exactly as
planned. For instance, there have been problems with
the implementation of the shared summary record
through Graphnet, meaning the MDT case management
may not have been delivered exactly as planned in every
detail (beyond the practice changes introduced by the
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MDTs in general, and of course the case management
those high-risk patients received).31 So, if the main
driver of results was the MDT working, we may plausibly
expect these effects to differ by risk group (ie, the
general practice being on average at lower risk).
Finally, direct and spillover effects may plausibly act
through distinct mechanisms. There are some indica-
tions of wider system effects of integrated care in the lit-
erature. For example, good team ‘climate’ (ie,
professional integration)14 has been linked to superior
clinical care for a number of LTCs,32 although evidence
of causation is currently lacking.33 This is one potential
mechanism that the MDT spillover effects could act
through. Spillover effects, therefore, may not be depend-
ent on the numbers captured by MDTs directly, because
they go via the GP and wider care team. If practices ‘do’
MDT for a few patients, it may inﬂuence their care for
everyone.
Strengths and weaknesses of the study
Our method of analysis, DD, is a robust method under
certain conditions that we tested.11 We only saw potential
bias indicated by non-parallel preintervention trends for
a single outcome measure at the individual level (out-
patient visits), and we employ robustness checks beyond
the primary analysis models. The method allows testing
of a complex intervention in routine practice, with
potential for greater external validity and generalisability
of the ﬁndings.12
Our results at both levels are plausible. At the individual
level, we observed very little differences between the
groups, as we would expect from previous literature around
this intervention type.6 At the practice level, the effect
we observed was on an outcome (inpatient non-elective
admissions) the intervention aimed to affect.16
However, our study does suffer from a number of
weaknesses. Unfortunately, due to the implementation
Table 6 Average absolute outcomes per 1000 patients per month by PICT (wave 1 compared to practices joining the
intervention at a later date), preintervention/postintervention
Outcome
Unadjusted means
(per 1000 patients per month)—wave 1 PICT
compared to later joining Unadjusted intervention effect
(difference per 1000 patients per month)Pre (before 2012m11) Post (after 2012m11) Difference
Primary outcomes
Inpatient non-electives
Controls 6.40 6.61 0.21
PICT 8.36 8.07 −0.29 −0.50
Inpatient electives
Controls 6.19 6.66 0.47
PICT 8.58 8.51 −0.07 −0.54
Outpatient admissions
Controls 87.64 97.33 9.69
PICT 116.86 127.11 10.25 0.56
A&E visits
Controls 25.91 28.64 2.73
PICT 31.42 34.11 2.69 −0.04
ACSCs
Controls 0.59 0.66 0.07
PICT 0.85 0.85 0 −0.07
Re-admissions (30 days)
Controls 0.87 0.84 −0.03
PICT 1.22 1.13 −0.09 −0.06
Secondary outcomes
Total cost of secondary care services (£)
Controls 29157.28 30530.70 1373.42
PICT 38923.43 39167.17 243.74 −1129.68
Length of stay (days)
Controls 60.32 50.97 −9.35
PICT 77.24 66.21 −11.03 −1.68
Patient satisfaction (general)
Controls 0.35 0.38 0.03
PICT 0.38 0.37 −0.01 −0.04
Patient satisfaction (LTC specific)
Controls 0.13 0.14 0.01
PICT 0.14 0.16 0.02 0.01
A&E, accident and emergency; ACSCs, ambulatory care sensitive conditions; LTC, long-term condition; PICT, Practice Integrated Care Team.
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of the intervention, we were not able to access
individual-level data until before the point where nearly
all practices implemented the intervention. This is due
to an initial problem at the CCG of consenting data use
for those individual patients initially included early in
the intervention. This limits our ability to ascertain
whether the initially recruited patients at each practice
were signiﬁcantly different, or beneﬁted more or less
than those recruited later to the intervention. It also
prevents direct comparison of the results we saw at the
practice level with those at the individual level over
exactly the same period of time and limits our ability to
look at any longer term effects of the intervention at the
individual level. Furthermore, if spillover effects did
indeed affect other patients in the practice, then the
individual-level effects may be driven towards the null.
This is similarly true for the DDD analysis conducted.
However, these spillover effects were not strongly indi-
cated at the practice level.
With the intervention so widespread (particularly
important for an intervention incentivised nationally),
we were extremely careful to choose our comparators (a
crucially important step in DD analysis). We chose prac-
tices (within the same CCG) for which we knew for def-
inite their intervention status at any time point for the
practice-level analysis. Nonetheless, practices volunteered
for the intervention, which can potentially introduce
some selection bias at the practice level. However, we
estimate this possible selection effect to be minimal
based on observable practice characteristics. A common
limitation of non-experimental studies, however, is we
cannot discount differences based on unobservables.
Adding practice ﬁxed effects controls for any differences
between practices that persist over time, as well as any
hospital-level changes during the period that affect all
practices.
At the individual level, we matched patients using pro-
pensity scores within the CCG achieving the necessary
parallel pretrends. However, the intervention patients
are selected for their immediate risk, while the control
patients were selected based on their matched risk at an
earlier date, which may have subsequently subsided (and
hence be the reason they were indeed not recruited to
the intervention). With ‘risk’, and so recruitment,
deﬁned on time-variant indicators, and so transient over
time, there is potential for some bias in favour of the
control group for the individual-level results in this ana-
lysis. However, with patients well matched at the initial
start date, we expect to have minimised this bias.
An important weakness, constrained by the data avail-
able to us, is we were not able to analyse outcomes
beyond secondary care utilisation and total cost of sec-
ondary care. While these utilisation outcomes reﬂect
well the explicit aims of the intervention, they do not
allow for a broad representation of the intervention in
terms of other important potential outcomes—for
example, patient health, quality of life and satisfaction
with care. These additional measures could be consid-
ered when making commissioning decisions, although
they were not the primary stated aim.
Results in relation to other studies
Our recent systematic review and meta-analysis looking
at similar interventions likewise showed little effect
across relevant health system outcomes for those
involved in the intervention directly (ie, non-signiﬁcant
estimated pooled ES of 0.04 for secondary care use in
the short term, and −0.02 in the long term).6 However,
the review did show a clear beneﬁt in terms of patient
satisfaction for these patients (statistically signiﬁcant esti-
mated pooled ES of 0.26 in the short term, and 0.35 in
the long term). We were unable to replicate this ﬁnding
Table 7 Practice-level adjusted model results
Outcome
Adjusted* intervention effect (95% CI)
(difference per 1000 patients per month)
Effect size†Linear regression model
Primary outcomes
Inpatient non-electives −0.63 (−1.17 to −0.09)‡ −0.24
Inpatient electives 0.19 (−0.47 to 0.86) 0.07
Outpatient visits −2.80 (−9.84 to 4.24) −0.08
A&E visits −1.32 (−3.52 to 0.89) −0.13
ACSCs −0.04 (−0.15 to 0.06) −0.08
Readmissions (30 days) −0.10 (−0.25 to 0.05) −0.16
Secondary outcomes
Total cost of secondary care services (£) −505.73 (−2763.35 to 1751.89) −0.04
Length of stay (days) −0.24 (−7.56 to 7.08) −0.01
Patient satisfaction (general) −0.03 (−0.09 to 0.02) −0.24
Patient satisfaction (LTC specific) 0.01 (−0.04 to 0.05) 0.14
N=1650 observations; 30 practices (period November 2010–March 2015).
*Adjusted for practice and time fixed effects with robust SEs.
†Standardised mean difference.
‡Significant at p<0.05.
A&E, accident and emergency; ACSCs, ambulatory care sensitive conditions; LTC, long-term condition.
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in this study, perhaps due to the data available to us that
only allowed us to look at this domain at the practice
level, which is likely to be less sensitive. We hypothesised
from the results of our review’s subgroup analyses that
case management by an MDT and involving a social
worker may be more effective than other examples also
included in the review (eg, single nurse case manager).
Results of this subsequent study do not support this pre-
vious hypothesis. However, we also suggested that ‘low-
strength’ primary care systems17 may beneﬁt more from
the intervention (where case management may substi-
tute for a strong primary care system). This may explain
this deviation from the results of our review, which drew
on evidence predominantly from a ‘low-strength’
primary care country (USA).
Looking at spillover effects from MDT case manage-
ment was a strength of this paper.14 Only a few other
studies have looked at spillover effects, most notably,
evaluation of the Evercare intervention.34 However,
Evercare used only a single case manager, where we
might not expect to ﬁnd large effects, and the study
identiﬁed no spillover.34 Analysis of MDT case manage-
ment in the English ‘Integrated Care Pilots’ (ICP) like-
wise looked at direct and spillover effects. Roland et al
identiﬁed an increase in emergency admissions and a
decrease in elective admissions and outpatient atten-
dances at the individual level. At the practice level, they
identiﬁed a slight reduction in outpatient attendances.
It is, however, difﬁcult to compare these results directly
with this study, with the ICP analysis evaluating six separ-
ate sites in combination, each offering slight alterations
of MDT case management to different populations.
Nevertheless, key differences that stand out include the
presence of a social worker in the case management
team in this intervention (only two smaller sites in the
ICP identiﬁed input from a social worker); physical
MDT meetings in this intervention rather than ‘virtual
ward’ rounds (as in the ICP sites); and the GP as clinical
lead in this intervention, rather than the primarily
nurse-led interventions in ICP sites.35
Implications for clinicians and policymakers
This study provides further evidence of the limited
effectiveness of MDT case management aimed at gener-
ally ‘at-risk’ patients as a tool to reduce care utilisation.
MDT case management targeted at high-risk patients
importantly does not achieve its primary aim: reducing
emergency admissions for those high-risk patients dir-
ectly managed. Therefore, there may be better alterna-
tives to this intervention, which may be other forms of
case management targeted at speciﬁc conditions, which
have some evidence of beneﬁcial results—for example
targeting mental health.36 Aiming at a very small
number of high-risk patients may never alleviate health
system pressures alone,30 and even the potential spillover
effects of increased professional integration that may
result may not be of sufﬁcient magnitude to achieve the
desired effects.
Going beyond the case management model to a more
population-based approach may therefore be another
avenue to explore, for example, colocation of services, or
integrated electronic health records for all patients
rather than just a high-risk cohort—interventions further
removed from the service delivery level, but which may
be regarded as a key foundation for multidisciplinary pro-
fessional communication and working. We have shown
here that this greater professional integration may have
scope for improving measurable health system outcomes.
Future research
More work is needed to conﬁrm these initial ﬁndings of
potentially beneﬁcial spillover effects, particularly quali-
tative work and process evaluation identifying plausible
mechanisms. These did not stand up to our robustness
checks in this analysis; however, the indication was always
in the direction of favouring the intervention practices
with regard to decreasing non-elective admissions at the
practice level. Where it is possible, future studies looking
at models of integrated care should consider spillover
effects.
If commissioning bodies consider evaluation using
similar robust, but cost-effective methods in the future,
they should be planned from the beginning, where
potential bias (discussed above) could be easily avoided.
For example, a randomised stepped-wedge design may
be an appropriate alternative.37
While we improved on previous literature by including
a measure of multimorbidity in our study, we only
included the most basic of these, a simple count of dis-
eases.38 Our future research will explore outcomes strati-
ﬁed by different ‘types’ of multimorbidities, to observe if
the intervention can be better targeted for the patients
it directly affects, providing a more effective and efﬁ-
cient method of exploiting the potential for wider
system effects.
CONCLUSIONS
We show that MDT case management does not fulﬁl its
primary aim, preventing emergency admissions for the
high-risk patients it targets. This accords with our previ-
ous ﬁndings. We show here that the highest risk patients
(as identiﬁed by the risk tool) receiving the intervention
in fact slightly increased admissions in many domains
targeted for decrease by the intervention. We do,
however, show some indications of beneﬁcial spillover
effects of MDT working at the practice level worthy of
further exploration. The results highlight the import-
ance of ongoing work on effective ways of avoiding
admissions.36
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